Article
Germ-line HER-2 variant and breast cancer risk by stage of disease.
Cancer research - 1 Dec 2001
McKean-Cowdin R, Kolonel L N, Press M F, Pike M C, Henderson B E
Abstract excerpt
HER-2 gene amplification and protein overexpression has been associated with increased risk of advanced-stage breast cancer and poor prognosis. Recently, a single missense point mutation (Ile(655)Val) in the transmembrane domain of the HER-2 gene was associated with a 40% increase in breast cancer risk among women 45 years of age and younger. In this analysis, we measured the association between the Ile(655)Val...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
